Volume 31, Issue 5 (August 2020)                   Stud Med Sci 2020, 31(5): 335-346 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Peirouvi T, Shalizar A, Mir Yaghoobipoor S S, Meghrazi K. PROTECTIVE EFFECTS OF LACTOFERRIN AGAINST DORORUBICIN TOXICITY ON MAIN GONAD OF RAT. Stud Med Sci. 2020; 31 (5) :335-346
URL: http://umj.umsu.ac.ir/article-1-5080-en.html
Department of Basic Sciences, School of Veterinary Medicine, Urmia University, Urmia, Iran (Corresponding Author) , ali_shalizar@yahoo.com
Abstract:   (435 Views)
Background & Aims: Doxorubicin has been widely used to treat solid tumors and blood malignancies, but its toxicity has limited its application. The aim of the present study was to investigate the protective effects of lactoferrin against doxorubicin toxicity on the main gonad of rats.
Materials & Methods: 24 Adult male Wistar rats were divided into four groups. Control group received physiological saline intraperitoneally and then orally, the second group received doxorubicin intraperitoneally, the third group received intraperitoneal doxorubicin, oral lactoferrin four hours after drug administration, and the fourth group received oral lactoferrin. The administration was performed weekly. After dissection, the testes of the animal were studied after tissue passage and staining.
Results: There was a statistically significant difference in mean diameter of seminiferous tubules between the control and doxorubicin groups and between the control and doxorubicin + lactoferrin groups (p≤0.05). There was also a statistically significant difference in mean diameter of seminiferous tubules between lactoferrin group and doxorubicin and doxorubicin + lactoferrin groups (p≤0.05). The mean difference between doxorubicin and doxorubicin + lactoferrin groups was also statistically significant (p≤0.05). There was a significant difference between the mean thickness of germinal epithelium between the control and doxorubicin groups and between the control and doxorubicin + lactoferrin groups (p≤0.05). There was also a statistically significant difference between lactoferrin group and doxorubicin and doxorubicin + lactoferrin groups (p≤0.05). Moreover, lactoferrin co-treatment led to a considerable increase of PCNA- and HSP70-positive cells compared to the doxorubicin-only group (p≤0.05).
Conclusion: Lactoferrin can be used to reduce the side effects of doxorubicin on reproductive organs such as the testis.
Full-Text [PDF 2789 kb]   (137 Downloads)    
Type of Study: Research | Subject: بافت شناسی

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2021 All Rights Reserved | Studies in Medical Sciences

Designed & Developed by : Yektaweb